Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

LENZLENZ
Showing 8 of 10 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in LENZ THERAPEUTICS INC

Yes. RA Capital Management holds 4,178,823 shares of LENZ (Lenz Therapeutics), worth $23.7M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. RA Capital Management has held LENZ in every 13F on record since Q1 2024, 10 quarterly filings. LENZ is 0.2% of RA Capital Management's reported 13F portfolio.

Current Value

$23.7M

Current Shares

4.2M

Total Value Change

-$75.5M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
4.2M
0.0%
$23.7M0.2%$5.68
0
2026-Q1
Unchanged
4.2M
0.0%
$38.2M0.4%$13.15
0
2025-Q4
Unchanged
4.2M
0.0%
$66.9M0.7%$16.12
0
2025-Q3
Unchanged
4.2M
0.0%
$194.6M2.4%$44.89
0
2025-Q2
Unchanged
4.2M
0.0%
$122.5M2.1%$30.18
0
2025-Q1
Unchanged
4.2M
0.0%
$107.4M1.8%$25.64
0
2024-Q4
Unchanged
4.2M
0.0%
$120.6M1.6%$30.07
0
2024-Q3
Unchanged
4.2M
0.0%
$99.2M1.1%$24.04
0

Other major holders of LENZ: BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used